Atria Wealth Solutions’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,640
Closed -$2.68M 1941
2025
Q1
$2.68M Buy
23,640
+8,328
+54% +$891K 0.03% 526
2024
Q4
$1.62M Sell
15,312
-334
-2% -$35.8K 0.02% 716
2024
Q3
$1.69M Sell
15,646
-417
-3% -$45.5K 0.02% 698
2024
Q2
$1.75M Buy
16,063
+617
+4% +$72.7K 0.02% 675
2024
Q1
$2.04M Sell
15,446
-1,872
-11% -$234K 0.02% 631
2023
Q4
$2.11M Sell
17,318
-3,248
-16% -$362K 0.03% 588
2023
Q3
$2.31M Buy
20,566
+1,144
+6% +$145K 0.03% 510
2023
Q2
$2.83M Buy
19,422
+4,735
+32% +$643K 0.04% 460
2023
Q1
$1.9M Sell
14,687
-467
-3% -$58.6K 0.03% 559
2022
Q4
$1.93M Buy
15,154
+757
+5% +$87.8K 0.03% 526
2022
Q3
$1.51M Sell
14,397
-238
-2% -$26.1K 0.03% 577
2022
Q2
$1.54M Buy
14,635
+12,344
+539% +$1.46M 0.03% 534
2022
Q1
$294K Buy
+2,291
New +$276K ﹤0.01% 1329

Other funds holding ZBH

Atria Wealth Solutions's ZBH Position: Q2 2025 in Review

Atria Wealth Solutions sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 23,640 shares — an estimated $2.68M sold.

Atria Wealth Solutions first reported a position in ZBH in Q1 2022 and held it in 13 quarters. The position peaked at $2.83M in Q2 2023. 937 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Atria Wealth Solutions reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Atria Wealth Solutions sold 23,640 Zimmer Biomet shares in Q2 2025, an estimated $2.68M.
  • Atria Wealth Solutions first reported a position in Zimmer Biomet in Q1 2022 and held it in 13 quarters.
  • Atria Wealth Solutions's Zimmer Biomet position peaked at $2.83M in Q2 2023.
  • 937 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.